Prevalence of Psychotropic Medication Use among German and Austrian Nursing Home Residents: A Comparison of 3 Cohorts

2012 ◽  
Vol 13 (2) ◽  
pp. 187.e7-187.e13 ◽  
Author(s):  
Tanja Richter ◽  
Eva Mann ◽  
Gabriele Meyer ◽  
Burkhard Haastert ◽  
Sascha Köpke
Keyword(s):  
Nursing Home ◽  
Psychotropic Medication ◽  
Medication Use ◽  
Nursing Home Residents

scholarly journals Psychotropic medication use among nursing home residents in Austria: a cross-sectional study

2009 ◽  
Vol 9 (1) ◽  
Author(s):  
Eva Mann ◽  
Sascha Köpke ◽  
Burkhard Haastert ◽  
Kaisu Pitkälä ◽  
Gabriele Meyer
Keyword(s):  
Nursing Home ◽  
Psychotropic Medication ◽  
Medication Use ◽  
Nursing Home Residents ◽  
Cross Sectional Study ◽  
Sectional Study ◽  
Cross Sectional

P4-260: Effect of Activities, Social Environment, and Psychotropic Medication Use on Behavioral Symptoms of Nursing Home Residents With Dementia

2016 ◽  
Vol 12 ◽  
pp. P1130-P1130
Author(s):  
Ben Remor Inventor ◽  
Carol J. Farran ◽  
Judith McCann ◽  
Olimpia Paun ◽  
Fawn A. Cothran ◽  
...  
Keyword(s):  
Nursing Home ◽  
Social Environment ◽  
Psychotropic Medication ◽  
Medication Use ◽  
Nursing Home Residents ◽  
Behavioral Symptoms

scholarly journals Current Psychotropic Medication Use and Contributing Factors Among Nursing Home Residents With Cognitive Impairment

2019 ◽  
pp. 105477381983867 ◽  
Author(s):  
Barbara Resnick ◽  
Ann Kolanowski ◽  
Kimberly Van Haitsma ◽  
Elizabeth Galik ◽  
Marie Boltz ◽  
...  
Keyword(s):  
Nursing Home ◽  
Cognitive Impairment ◽  
Psychotropic Medication ◽  
Medication Use ◽  
Nursing Home Residents ◽  
Contributing Factors

scholarly journals A tablet-based intervention for activating nursing home residents with dementia: results from a cluster-randomized controlled trial

2021 ◽  
pp. 1-13
Author(s):  
Julie L. O’Sullivan ◽  
Sonia Lech ◽  
Paul Gellert ◽  
Ulrike Grittner ◽  
Jan-Niklas Voigt-Antons ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Randomized Controlled Trial ◽  
Nursing Home ◽  
Nursing Homes ◽  
Psychotropic Medication ◽  
Controlled Trial ◽  
Nursing Home Residents ◽  
Randomized Controlled ◽  
Cluster Randomized

Abstract Objectives: To investigate global and momentary effects of a tablet-based non-pharmacological intervention for nursing home residents living with dementia. Design: Cluster-randomized controlled trial. Setting: Ten nursing homes in Germany were randomly allocated to the tablet-based intervention (TBI, 5 units) or conventional activity sessions (CAS, 5 units). Participants: N = 162 residents with dementia. Intervention: Participants received regular TBI (n = 80) with stimulating activities developed to engage people with dementia or CAS (n = 82) for 8 weeks. Measurements: Apathy Evaluation Scale (AES-I, primary outcome), Quality of Life in Alzheimer’s Disease scale, QUALIDEM scale, Neuropsychiatric Inventory, Geriatric Depression Scale, and psychotropic medication (secondary outcomes). Momentary quality of life was assessed before and after each activity session. Participants and staff were blinded until the collection of baseline data was completed. Data were analyzed with linear mixed-effects models. Results: Levels of apathy decreased slightly in both groups (mean decrease in AES-I of .61 points, 95% CI −3.54, 2.33 for TBI and .36 points, 95% CI −3.27, 2.55 for CAS). Group difference in change of apathy was not statistically significant (β = .25; 95% CI 3.89, 4.38, p = .91). This corresponds to a standardized effect size (Cohen’s d) of .02. A reduction of psychotropic medication was found for TBI compared to CAS. Further analyses revealed a post-intervention improvement in QUALIDEM scores across both groups and short-term improvements of momentary quality of life in the CAS group. Conclusions: Our findings suggest that interventions involving tailored activities have a beneficial impact on global and momentary quality of life in nursing home residents with dementia. Although we found no clear advantage of TBI compared to CAS, tablet computers can support delivery of non-pharmacological interventions in nursing homes and facilitate regular assessments of fluctuating momentary states.

Improving psychotropic medication use among persons with dementia

2016 ◽  
Vol 28 (10) ◽  
pp. 1587-1588 ◽  
Author(s):  
Donovan T. Maust
Keyword(s):  
United States ◽  
Older Adults ◽  
Nursing Home ◽  
Psychotropic Medication ◽  
Medication Use ◽  
The United States ◽  
Black Box ◽  
Community Settings ◽  
Limited Evidence

The use of psychotropic medication among persons with dementia (PWD) both in nursing home (Wetzels et al., 2011) and community settings (Maust et al., 2016) far exceeds what might be expected based on their limited evidence for benefit (Kales et al., 2015). This relatively high use persists despite years of evidence about the potential harms associated with their use in older adults generally and PWD in particular (e.g. Wang et al., 2001; Schneider et al., 2005). However, the solution to relatively high psychotropic use is not to end all psychotropic use, as there are individual patients for whom use of such medication is appropriate. For example, a policy that defines all antipsychotic use as inappropriate may simply lead to increased use of alternatives with even less evidence of benefit, as suggested by the response to antipsychotics’ black box warning in the United States (Kales et al., 2011).

Sign in / Sign up

Export Citation Format

Share Document